Insights

The Early Stage Biotech Playbook

Beyond novel science, high-performing biotech organizations have mastered something essential: a resilient operational foundation that fuels value creation without draining…

Insights

How to Build a Biopharma Market Access Strategy: 4 Crucial Steps to Take

Biopharma companies need more than just strong clinical data to succeed; they need a well-planned biopharma market access strategy. With…

Insights

Emerging from Stealth: Countdown to a High-Impact Biotech Company Launch

Expert Insights from Liza Sullivan, Managing Director, Argot Partners, a Danforth Advisors company Emerging from stealth mode is a pivotal…

Insights

Choosing the Right Clinical Outsourcing Partner: 3 Things to Consider

or small biopharma companies, outsourcing clinical operations is often essential, but choosing the wrong clinical outsourcing partner can lead to…

Corporate News

Danforth Advisors Establishes Market Access Division

Appoints Scotty Bowman as Managing Director WALTHAM, Mass. – June 11, 2025 – Danforth Advisors LLC today announced the launch…

Insights

The Connection Point: Transforming Pharmaceutical Data into Strategic Intelligence

Insights From an Expert: Written by David Albini, EVP of Data Transformation, BW Health Group, A Danforth Advisors Company Medical…

Insights

Simplify for Success: A Biotech Commercialization Strategy That Works

Insights From an Expert: Written by Chris Mycek, Head of Commercialization, Benchworks A strong biotech commercialization strategy is crucial for…

Insights

Performance Management in Biotech: 3 Ways to Support Your People

It’s time to rethink performance management and reviews, especially in fast-moving industries like biotech, where annual feedback cycles are too…

Insights

CRO Selection Strategy: Reframing the Question for Clinical Trial Success

Insights From Richard Polgar, Managing Director, Danforth Advisors One common question biotech leaders consistently ask is, “Who’s the right CRO…